BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220113T120000
DTEND;TZID=America/New_York:20220113T130000
DTSTAMP:20260407T042018
CREATED:20220110T165326Z
LAST-MODIFIED:20220110T165326Z
UID:10001424-1642075200-1642078800@www.med.unc.edu
SUMMARY:Medicine Grand Rounds – Sid Barritt: “Nonalcoholic Fatty Liver Disease: New Diagnostic Approaches and Therapeutic Interventions for 2022”
DESCRIPTION:  \nSidney Barritt IV\, MD\, MSCR\, is a tenured associate professor at the University of North Carolina. He is the Director of Hepatology in the UNC liver center and the Transplant Hepatology Fellowship Program Director. Dr. Barritt conducts clinical outcomes research in nonalcoholic fatty liver disease (NAFLD)\, general hepatology\, and liver transplantation.  Dr. Barritt leads the UNC Liver Center’s clinical trial program in NAFLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials and is also a member of the NIH sponsored Drug Induced Liver Injury Network and the PCORI PAL-Liver study.  Dr. Barritt is also a founding PI for an international registry of patients with liver disease and SARS-CoV2 infection called SECURE-Liver.  Dr. Barritt is a collaborator and advisor to multiple other investigators in the allied schools of health\, including the Gillings School of Global Public Health\, the Eshelman School of Pharmacy\, and the UNC Adams School of Dentistry.  Dr. Barritt is a Fellow of the American Association for the Study of Liver Disease and the American College of Gastroenterology.  Outside of work\, Dr. Barritt enjoys spending time with his family\, road running\, and triathlons.
URL:https://www.med.unc.edu/medicine/event/medicine-grand-rounds-sid-barritt-nonalcoholic-fatty-liver-disease-new-diagnostic-approaches-and-therapeutic-interventions-for-2022/
END:VEVENT
END:VCALENDAR